600 MILLION STRAY DOGS NEED YOU: Form 990, tax year 2025
View the entire original 990 at ProPublica ↗
- Organization
- 600 MILLION STRAY DOGS NEED YOU (EIN 33-0601340)
- Tax period
- 2025-01-01 to 2025-12-31
- Filed
- 2026-07-06
- IRS object ID
- 202601889349300300
- Schema version
- 2025v4.2
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2026-07-06T23:02:09-05:00 | ReturnTs |
| Tax Period End | 2025-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Anthony Mansueto CPA | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1325 Warnall Ave | AddressLine1Txt |
| City | Los Angeles | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 90024 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2025-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 330601340 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | 600 Million Stray Dogs | BusinessNameLine1Txt |
| Business Name Line2 | Need You Corporation | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | 600M | BusinessNameControlTxt |
| Phone | 9544649331 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | PO Box 1065 | AddressLine1Txt |
| City | Pompano Beach | CityNm |
| State Abbreviation | FL | StateAbbreviationCd |
| ZIP | 33061 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | Alexander Pacheco | PersonNm |
| Person Title | President | PersonTitleTxt |
| Phone | 9544649331 | PhoneNum |
| Signature | 2026-07-06 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | Anthony Mansueto | PreparerPersonNm |
| PTIN | P02488692 | PTIN |
| Phone | 3108955992 | PhoneNum |
| Preparation | 2026-07-01 | PreparationDt |
| Self Employed | Yes (X) | SelfEmployedInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2025 | TaxYr |
| Build TS | 2025-03-06 01:10:19Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | 600 Million Dogs 600milliondogsorg | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | Alexander Pacheco | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | PO Box 1065 | AddressLine1Txt |
| City | Pompano Beach | CityNm |
| State Abbreviation | FL | StateAbbreviationCd |
| ZIP | 33061 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $711,807 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | www.600milliondogs.org | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2009 | FormationYr |
| Legal Domicile State | FL | LegalDomicileStateCd |
| Activity Or Mission | To end the #1 cause of suffering and death for dogs and cats globally, by* continued on Schedule O *continued from page 1* developing food that will spay and neuter them, without surgery and end the overpopulation problem without killing. | ActivityOrMissionDesc |
| Voting Members Governing Body | 3 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 2 | VotingMembersIndependentCnt |
| Total Employee | 2 | TotalEmployeeCnt |
| Total Volunteers | 35 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $459,413 | PYContributionsGrantsAmt |
| CY Contributions Grants | $647,447 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $38,917 | PYInvestmentIncomeAmt |
| CY Investment Income | $64,360 | CYInvestmentIncomeAmt |
| PY Other Revenue | $0 | PYOtherRevenueAmt |
| CY Other Revenue | $0 | CYOtherRevenueAmt |
| PY Total Revenue | $498,330 | PYTotalRevenueAmt |
| CY Total Revenue | $711,807 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $350 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $0 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $135,746 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $132,886 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $42,347 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $374,782 | PYOtherExpensesAmt |
| CY Other Expenses | $361,444 | CYOtherExpensesAmt |
| PY Total Expenses | $510,878 | PYTotalExpensesAmt |
| CY Total Expenses | $494,330 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$12,548 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $217,477 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $831,385 | TotalAssetsBOYAmt |
| Total Assets EOY | $1,116,991 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $200,000 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $200,000 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $631,385 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $916,991 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | To end the #1 cause of suffering and death for dogs and cats globally, by developing food that will spay and neuter them, without surgery and end the overpopulation problem without killing. Humane education; fighting to prevent the suffering of children and all animals. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $407,478 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Desc | Science Overview for 2025 and the Global Problem We Seek to Solve1) It is believed by many that the global crisis of homeless companion animal overpopulation, the number one cause of suffering for dogs and cats, increased throughout 2025 as their primary source of food increased: human garbage. Millions of homeless dogs and cats continued to suffer as the cycle of reproduction of the homeless by the homeless repeated generation after generation. To end this suffering, our mission remained science-driven and unprecedented: to end the Number One cause of *continued on Sch O *continued from page 2* suffering and premature death for dogs and cats worldwide -overpopulation - by advancing the development of what will become the first one-dose, edible, permanent-lasting birth control formula capable of safely sterilizing stray dogs and cats without surgery.Recognizing that traditional spay and neuter surgery alone cannot solve this problem worldwide, we continued advancing the development of the Spay and Neuter Cookie as a cruelty-free, scalable, science-based, effective alternative. Building upon prior progress, we continued testing chemicals to produce lifelong sterilization from a single cookie, while our small dedicated team continued advancing this groundbreaking and complex scientific work, despite serious constraints ranging from threats and harassment to insufficient resources and funding. 2) In 2025, we were compelled to spend a substantial amount of effort improving the crucial analysis of 'the follicle count'. Before delving into these specifics, it is important to understand why the follicle count is so important.In short, the follicle count tells us whether our birth-control formula is actually working. Follicles are located in the ovaries, and once a follicle dies (usually with advancing age), it cannot be replaced, and without enough follicles, reproduction cannot take place. This natural condition in humans is referred to as menopause. As our goal is to develop a single-dose, permanent, lasting birth control treatment for dogs and cats, the most important question is: Did our formula permanently shut down the ovary's ability to produce future eggs? The follicle count helps answer that question.Before the follicle count: Researchers often had to rely on indirect clues: Did the animal become pregnant? Or did hormone levels change? Any number of questions. The problem is that these clues can be misleading. The follicle count gives us a more direct answer. By carefully examining treated ovarian tissues and analyzing their follicles, we can determine: How many follicles remain. What types of follicles remain? Whether the treatment damaged only some follicles or nearly all of them, and so on.Why this matters: We are not trying to create a birth control method that works for a few months. We are working to develop something far more ambitious: A safe, inexpensive, edible, one-dose treatment that permanently prevents reproduction - without the need for capture, injections or surgery. To prove that such a treatment truly works, we need evidence that the formula has eliminated, or sufficiently depleted, the viable ovarian reserve. The follicle count is one of the strongest ways to demonstrate that. A robust follicle-count method can help answer questions from: Scientific reviewers, Grant agencies, Regulatory authorities, Veterinary experts, and Potential partners. It provides objective evidence rather than relying on assumptionsIn short: The follicle count is important because it allows us to directly measure whether our one-dose formula has permanently disabled the ovary's capacity to produce fertile eggs that are necessary for becoming pregnant - the central requirement for ending the uncontrolled reproduction in stray dogs and cats.3) Analyzing the Follicle: Our Attempts to Automate Pathology Reporting with Artificial Intelligence. In 2025 we invested significant time in attempting to automate our pathology reporting using AI, hoping to speed up the expensive, labor-intensive work of evaluating follicles digital slide by digital slide. Unfortunately, this effort was not successful. AI-based classification and analysis is simply not good enough yet to meet our needs. Unfortunately it does not yet meet the level of accuracy that our work demands. In short, the variability and subtlety that we require, in follicle detection and staging, continued to exceed what current automated tools could/can reliably handle. While the experiments did not deliver the time savings we had hoped for, they clarified where automation can and cannot yet be trusted, and it reinforced why our rigorous, human-led pathology, and tools like our follicle quiz, remain essential. 4) To deal with this important problem, we developed the follicle quiz pipeline - the follicle quiz for short. Much effort had to be invested in developing the follicle quiz. The need for it grew directly out of a problem we kept running into: we observed real variability and differences in follicle detection and classification - across different veterinary pathologists, and there was no easy way to understand or quantify or localize where those disagreements were coming from or what they were based on. As the accuracy of each formula depends on how reliably follicles are counted and staged, this kind of variation is not something we could, nor can, afford to leave unresolved. Static annotations and side discussions were and are, not enough. We needed a way to directly visualize and compare how different pathologists were interpreting the same raw material: treated follicles. This is why we had to build a structured comparison tool ourselves.Although the result appears to be a single, rather simple yet highly structured product, in the form of an online platform, getting there required a deeply involved process, requiring several structured, interconnected steps. We first evaluated annotation software such as ImageScope and QuPath, and after careful testing and comparison we found QuPath to be more suitable and easier to build a workflow around, and therefore decided to proceed with it. We then turned to image extraction and processing: to enable analysis at the level of individual follicles, one by one in a format easy for both pathologists and non-pathologists to work with. To accomplish this we also needed to convert each annotated follicle into a standalone image, which required developing a pipeline to extract annotated regions (of digital histological slides of our treated ovaries) from whole-slide images and save them as individual online files. Finally, we built the follicle quiz platform itself, both frontend and backend interactively refining it for functionality and usability, integrating the image processing pipeline with the quiz system, and carrying out multiple rounds of testing to ensure correctness, stability, and reliability. In other words we built an online platform that allows multiple pathologists to all examine the same 100 to 1,000 treated follicles, at the same time, and analyze each follicle at the same time, in a user friendly much more time efficient manner than ever before, and ultimately, deliver the combined data to us in format that makes it much easier to compare and understand the analysis by each pathologist individually and as a group. 5) Digital Slide Quality and Proper Ovarian Histology: We discovered that not all of the digital slides were quite up to standard, and we decided to search for companies capable of preparing them at the highest level. Slide quality is not a minor detail, it determines whether our follicle counts are meaningful. To properly evaluate the treated ovary, the objective is to obtain a true cross-section that includes all key anatomical components, and in their correct spatial relationship. The follicles themselves are stratified by developmental stage: for example, the most immature primordial and primary follicles are typically clustered in the outermost region of the cortex, just deep to the capsule, while secondary and tertiary follicles are found deeper within the cortex as they mature. To continue to accurately assess the follicular population, for example for follicular counts or staging , the histological slide must represent this complete architecture. We spent considerable time getting this right, because without it, even a perfectly designed formula may not be reliably evaluated, which of course is unacceptable. 6) As to be expected, we encountered some related problems which we also had to resolve, for example in the case of Pilot Pup Allie. Her treated tissue on the slide was problematic because the section appeared to miss or underrepresent the follicle-bearing cortical region, possibly due to tissue orientation within the cassette or sectioning near the pole of the ovary. We deemed the slide as essentially non-diagnostic for our follicular analysis | Desc |
| Total Program Service Expenses | $407,478 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | 0 | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | 0 | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | 0 | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | 0 | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | 0 | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | Yes (1) | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | 0 | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | 0 | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | 0 | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | 0 | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 0 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Employee | 2 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 3 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 2 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | Yes (1) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Alexander Pacheco | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 9544649331 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | PO Box 1065 | AddressLine1Txt |
| City | Pompano Beach | CityNm |
| State Abbreviation | FL | StateAbbreviationCd |
| ZIP | 33061 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (3 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd |
|---|---|---|---|---|---|---|
| Jeff Fraizer ESQ | ||||||
| Director | 1.00 | Yes (X) | $0 | $0 | $0 | |
| Alexander Pacheco | ||||||
| CEO, President | 50.00 | $43,030 | $0 | $0 | Yes (X) | |
| Mary Pacheco | ||||||
| Histology Supervisor | 1.00 | $0 | $0 | $0 | Yes (X) | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $43,030 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $0 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 0 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | 0 | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
| Cntrct Rcvd Greater Than100 K | 0 | CntrctRcvdGreaterThan100KCnt |
| All Other Contributions | $647,447 | AllOtherContributionsAmt |
| Total Contributions | $647,447 | TotalContributionsAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $64,360 | TotalRevenueColumnAmt |
| Exclusion | $64,360 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $711,807 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $64,360 | ExclusionAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $43,030 | TotalAmt |
| Program Services | $33,780 | ProgramServicesAmt |
| Management And General | $4,676 | ManagementAndGeneralAmt |
| Fundraising | $4,574 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $83,382 | TotalAmt |
| Program Services | $69,109 | ProgramServicesAmt |
| Management And General | $9,100 | ManagementAndGeneralAmt |
| Fundraising | $5,173 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,474 | TotalAmt |
| Management And General | $6,474 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,890 | TotalAmt |
| Management And General | $3,890 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,309 | TotalAmt |
| Management And General | $1,971 | ManagementAndGeneralAmt |
| Fundraising | $338 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $40,024 | TotalAmt |
| Program Services | $28,018 | ProgramServicesAmt |
| Management And General | $4,081 | ManagementAndGeneralAmt |
| Fundraising | $7,925 | FundraisingAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $38,397 | TotalAmt |
| Program Services | $29,152 | ProgramServicesAmt |
| Management And General | $4,339 | ManagementAndGeneralAmt |
| Fundraising | $4,906 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,789 | TotalAmt |
| Program Services | $5,602 | ProgramServicesAmt |
| Management And General | $168 | ManagementAndGeneralAmt |
| Fundraising | $1,019 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,702 | TotalAmt |
| Management And General | $3,702 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | FundraisingFundraisingAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|---|
| RECRUITING MEMBER COMMU | $164,036 | $146,625 | $17,411 | |
| R AND D PROGRAM AND SUP | $95,192 | $95,192 | ||
| Healthcare | $3,674 | $3,674 | ||
| GOVERNMENT BANK FEES | $2,176 | $1,001 | $1,175 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,255 | TotalAmt |
| Management And General | $1,255 | ManagementAndGeneralAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $494,330 | TotalAmt |
| Program Services | $407,478 | ProgramServicesAmt |
| Management And General | $44,505 | ManagementAndGeneralAmt |
| Fundraising | $42,347 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $114,368 | BOYAmt |
| EOY | $333,681 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $717,017 | BOYAmt |
| EOY | $783,310 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $831,385 | BOYAmt |
| EOY | $1,116,991 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $200,000 | BOYAmt |
| EOY | $200,000 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $200,000 | BOYAmt |
| EOY | $200,000 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Org Does Not Follow FASB117 | Yes (X) | OrgDoesNotFollowFASB117Ind |
Cap Stk Tr Prin Current Funds CapStkTrPrinCurrentFundsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Pd In Cap Srpls Land Bldg Eqp Fund PdInCapSrplsLandBldgEqpFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rtn Earn Endowment Incm Oth Fnds RtnEarnEndowmentIncmOthFndsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $285,606 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $631,385 | BOYAmt |
| EOY | $916,991 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $831,385 | BOYAmt |
| EOY | $1,116,991 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $217,477 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $68,129 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Cash | Yes (X) | MethodOfAccountingCashInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | 0 | FSAuditedInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $507,576 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $278,460 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $293,174 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $459,413 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $647,447 | CurrentTaxYearAmt |
| Total | $2,186,070 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $507,576 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $278,460 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $293,174 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $459,413 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $647,447 | CurrentTaxYearAmt |
| Total | $2,186,070 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support Total170 | $2,186,070 | PublicSupportTotal170Amt |
| Total Support | $2,186,070 | TotalSupportAmt |
| Public Support CY170 | 1.00000 | PublicSupportCY170Pct |
| Public Support PY170 | 1.00000 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule F IRS990ScheduleF
Account Activities Outside US AccountActivitiesOutsideUSGrp (3 entries)
| RegionRegionTxt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|
| East Asia and the Pacific - Australia, Brunei, Burma, Cambodia, | 3 | Program research. Organic chemistry. Clinical support. | Program research. Organic chemistry. Clinical support. | $18,810 |
| South Asia - Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, | 4 | Animal rescue. Veterinary care. Clinical studies. Program research. | Animal rescue. Veterinary care. Clinical studies. Program research. | $65,011 |
| Europe (Including Iceland & Greenland) | 1 | Program research. Organic chemistry. Clinical support. | Program research. Organic chemistry. Clinical support. | $560 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 8 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 8 | TotalEmployeeCnt |
| Subtotal Spent | $84,381 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $84,381 | TotalSpentAmt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (7 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Form 990, Part III, Line 4a | needs because the section did not include enough of the cortical tissue where the follicles are located. In the same group (of 4) as Allie, the slide from Pilot Pup Lila was perfect - though the 3rd and 4th slides both had issues with orientation of the tissues within the cassette, but with slightly different outcomes. Solving this required us to deliver more explicit instructions to the histology processing companies, which they then needed to carry out. 7) Another problem we had to find a solution to is illustrated by the case of Pilot pup Abbey, where her tissue was sectioned on a tangential or oblique plane, rather than a true cross-section. The blade appeared to have passed through the ovary at a more shallow, non-perpendicular angle. The section appeared to include a larger proportion of the deeper cortex. This creates a distorted view that artificially enriches the population of secondary follicles while simultaneously missing the outer cortex where the primordial/primary follicles reside. The slide was not representative of the true follicular distribution; it created a misleading artifact of follicular dynamics by selectively over- and under-representing different zones. In this instance, the anatomical integrity of the cortex-medulla relationship was not fully captured, preventing a valid histopathological analysis of the follicular population. Again, solving this required us to deliver more explicit instructions to the histology processing companies, which they then needed to carry out. 8) In 2025, we of course continued advancing our evaluation of reproductive blockers and ovotoxicants - while continuing to develop formulations to meet the six criteria we deem to be essential to produce a practical, edible, cruelty-free and scalable non-surgical sterilization solution to the global overpopulation problem, starting with dogs and cats before advancing to other species in need. We were able to increase our understanding of ingredient interactions and outcomes, including evaluating promising new chemical candidates, with compound discovery work through good old fashioned scientific review and database research. 9) We also continued advancing active ingredient optimization strategies (as in developing new formulations) to improve single-dose effectiveness - while staying within self imposed boundaries, for safety and to remain cruelty-free. This included integrating multiple active and inactive ingredients into single-dose formulations to improve three crucial elements: Ingredient compatibility. Product stability. Product integrity. Including: preserving effectiveness under real-world conditions - which is easier said than done. 10) International vs. U.S. Trials: We continued advancing our research in cost-effective international settings, with the goal of saving enough funds to transfer into the U.S. to pursue the FDA and USDA processes necessary for deployment of the future Spay and Neuter Cookie, in the U.S. 11) Outreach and Advocacy: We continued advancing our outreach and advocacy efforts to raise awareness of animal suffering beyond overpopulation, and encourage public action on behalf of suffering animals worldwide regardless of the cause of their suffering. We continued educating and mobilizing our supporters and subscribers (approaching 50,000) through digital communications and advocacy initiatives, to fight cruelty to all animals. |
| Form 990, Part VI, Section A, line 2 | 2 MEMBERS BOARD OF DIRECTORS MARY AND ALEX PACHECO ARE RELATED; NO BUSINESS RELATIONSHIP. |
| Form 990, Part VI, Section A, line 7a | The Board and President also have the authority to elect members of the governing body. |
| Form 990, Part VI, Section B, line 11b | The organization formalized three standing committees: Finance, Audit and Compensation Review. These committees along with the Board are sent a draft of the 990 in advance for their review and input prior to filing. |
| Form 990, Part VI, Section B, line 12c | BY ASKING VENDORS AND FUND RECIPIENTS IF THEY HAD OR HAVE ANY - RELATIONSHIPS WITH BOARD MEMBERS AND VICE VERSA. |
| Form 990, Part VI, Section B, line 15 | THE BOARD CONDUCTED STANDARD COMPENSATION REVIEW |
| Form 990, Part VI, Section C, line 19 | THE ORGANIZATION MADE THESE MATERIALS AVAILABLE - UPON REQUEST |
Comments